Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes
Phase of Trial: Phase IV
Latest Information Update: 11 Oct 2017
At a glance
- Drugs Exenatide (Primary) ; Antihyperglycaemics; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 06 Oct 2017 Planned End Date changed from 1 Dec 2017 to 1 Mar 2018.
- 06 Oct 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Dec 2017.
- 10 Jun 2017 Biomarkers information updated